首页> 外文期刊>Journal of Chromatography, Biomedical Applications >Improved selectivity in detection of polar basic drugs by liquid chromatography-electrospray ionizatio mass spectrometry Illustration using an assay method for the determination of famotidine in human plasma
【24h】

Improved selectivity in detection of polar basic drugs by liquid chromatography-electrospray ionizatio mass spectrometry Illustration using an assay method for the determination of famotidine in human plasma

机译:液相色谱-电喷雾电离质谱法检测极性碱性药物的选择性得到提高,测定方法可用于测定人血浆中法莫替丁

获取原文
获取原文并翻译 | 示例
           

摘要

It is well to assume that bioanalytical chromatographic methods for the detemination of polar basic drugs are developed and optimised according to a standardised procedure which involves two alternatives: (a) modifications in the sample preparationn procedures, and (b) changes in the stationary phase of the chromatographic system. In this paper, a simple and rapid chromatographic procedure using a specific analytical detection method (ESI tandem mass spectrophotometric detection) in combination with a fast and efficient sample work-up procedure, protein precipitation, is presented. A demonstration of the entire chromatographic procedure is given for an HPLC method for the determination of famotidine in human plasma, a basic polar drug with poor solubility in organic solvents. In order to optimize the mass detection of famotidine, several parameters such as ionization mode, fragmentor voltage, m/z ratios of ions monitored, type of organic modifier and eluent additive, were investigated. Each analysis required 5 min. The calibration curve of famotidine in the range 1-200 ng/ml was linear with a correlation coefficient of 0.9992 (n=6), and a detection limit a signal-to-noise ratio of 3 was aprox 0.2 ng/ml. The within- and between-day variations in the famotidine analysis were 5.2 (n=6) and 6.7% (n=18), repectively. The applicability of this method was also demonstrated for the analysis of polasma samples in a Phase-I human pharmacokinetic stydy.
机译:可以很好地假设,根据标准程序开发并优化了用于测定极性碱性药物的生物分析色谱方法,该方法涉及两种选择:(a)修改样品制备程序,以及(b)固定相的改变。色谱系统。本文介绍了使用特定分析检测方法(ESI串联质谱检测)和快速高效的样品处理程序,蛋白质沉淀的简单,快速的色谱程序。给出了用于测定人血浆中法莫替丁的HPLC方法的整个色谱程序的证明,该法莫替丁是在有机溶剂中溶解度较差的碱性极性药物。为了优化法莫替丁的质量检测,研究了多个参数,例如电离模式,碎裂电压,所监测离子的m / z比,有机改性剂和洗脱液添加剂的类型。每次分析需要5分钟。法莫替丁在1-200 ng / ml范围内的校准曲线是线性的,相关系数为0.9992(n = 6),检出限为3的信噪比约为0.2 ng / ml。法莫替丁分析的日内和日间差异分别为5.2(n = 6)和6.7%(n = 18)。还证明了该方法在I期人类药代动力学设计中分析血浆样品的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号